Publisher
Springer International Publishing
Reference56 articles.
1. Bambha K, Kim WR, Tawalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125(5):1364–9.
2. Boberg KM, Aadland E, Jahnsen J, et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1999;33(1):99–103.
3. Schrumpf E, Fausa O, Elgio K, et al. Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis. 1988;8:201–9.
4. Wiesner R, Grambsch P, Dickson E, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989;10:430–6.
5. Loftus E, Harewood G, Loftus C, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–6.